op researchers from across the country will tackle metastatic breast cancer and implement new strategy
The Voice of Canada News:
Current treatments for metastatic breast cancer, including new immunotherapies, are ineffective for disease that has spread to other organs. That is why the Canadian research community is collaborating to accelerate cancer research to address the most pressing problems in breast cancer prevention, diagnosis, and treatment.
Marc Miller, Parliamentary Secretary to the Minister of Crown-Indigenous Relations and Member of Parliament for Ville-Marie–Le Sud-Ouest–Île-des-Sœurs, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, announced the new Stand Up to Cancer Canada (SU2C)—Canadian Cancer Society Metastatic Breast Cancer Dream Team. This team will focus efforts to implement advances in metastatic breast cancer research to improve the health of patients.
Drs. Nahum Sonenberg and Michael N. Pollak from McGill University will be leading the Dream Team composed of world-leading Canadian researchers from various disciplines. Together, they will study drugs to effectively treat metastatic breast cancer. More specifically, they will carry out a pan-Canadian clinical trial testing a new therapeutic strategy to determine how the drugs work and how future treatments can be improved. The multidisciplinary team will share data, methods and information among its members with advice from patient advocates to ensure progress in this innovative project. Finally, they will develop plans to rapidly bring their successful approaches to the clinic for the benefit of patients.
The Dream Team will receive up to $6 million over four years from SU2C Canada, the Canadian Cancer Society, and the Government of Canada through the Canadian Institutes of Health Research (CIHR). Scientific management and oversight is provided by SU2C Canada’s Scientific Partner, the American Association for Cancer Research International-Canada.
Mr. Miller made the announcement at McGill University, where he participated in a lab tour led by the Dream Team.
